Genewiz

GENEWIZ, founded in 1999 and acquired by Azenta Life Sciences, has evolved from a sequencing service provider into a comprehensive, regulated genomics solutions partner. Its core strategy leverages a global laboratory network and a deeply integrated, quality-controlled service infrastructure to accelerate scientific discovery and regulatory submissions for clients. Key achievements include establishing a significant competitive moat through its CAP/CLIA-accredited clinical lab and leveraging Azenta's complementary sample management ecosystem to offer an end-to-end service pipeline from sample collection to data analysis.

Integrated genomics and multiomics service infrastructure featuring state-of-the-art sequencing, synthesis, and molecular biology labs, coupled with a GLP-compliant, CAP/CLIA-accredited regulated services platform and full sample management ecosystem via Azenta.

GENEWIZ competes with large CROs (e.g., LabCorp), pure-play genomics service firms (e.g., Eurofins), and client in-house labs. Its competitive moat is built on its combined GLP/CAP/CLIA accreditations and its unique, integrated sample-to-data solution via Azenta, which competitors cannot easily replicate.